Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 1248-1255, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shultz, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shultz, E. K.

Clinical Chemistry, Vol 41, 1248-1255, Copyright © 1995 by American Association for Clinical Chemistry

Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example

EK Shultz
Program in Medical Information Science, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

The evolution of test performance analysis should include the long-term costs and benefits associated with testing. Evolutionary laboratory techniques to achieve this include introduction of a new methodological technique, a multivariate extension to a current analytical technique, receiver-operating characteristic (ROC) curve analysis (MultiROC analysis). This extension to ROC methodology allows the comparison of composite test rules in a format similar to that of ROC curves. Statistical properties, guidelines for use, and a detailed example are described. MultiROC is used in the outcomes analysis of the value of screening for prostate cancer. The effect of age and different test decision thresholds are examined in an extension of a previously published outcomes analysis. The results indicate that the variations in test performances caused by these components are important in assigning a final cost:benefit ratio of screening for prostate cancer.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Tsigkou, D. Marrelli, F. M. Reis, S. Luisi, A. L. Silva-Filho, F. Roviello, S. A. Triginelli, and F. Petraglia
Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2526 - 2531.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Vasan
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Circulation, May 16, 2006; 113(19): 2335 - 2362.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
V. A. DeBari
Computation of decision levels from differentiated logistic regression probability curves.
Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 194 - 200.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. R. Henderson
A Triptych of Statistics
Clin. Chem., November 1, 2003; 49(11): 1959 - 1962.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Stoeber, R. Swinn, A. T. Prevost, P. de Clive-Lowe, I. Halsall, S. M. Dilworth, J. Marr, W. H. Turner, N. Bullock, A. Doble, et al.
Diagnosis of Genito-Urinary Tract Cancer by Detection of Minichromosome Maintenance 5 Protein in Urine Sediments
J Natl Cancer Inst, July 17, 2002; 94(14): 1071 - 1079.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Robertson, T. Stephenson, E. Pruysers, P. McCloud, A. Tsigos, N. Groome, P. Mamers, and H. G. Burger
Characterization of Inhibin Forms and Their Measurement by an Inhibin {alpha}-Subunit ELISA in Serum from Postmenopausal Women with Ovarian Cancer
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 816 - 824.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. Brathen, K. S Bjerve, E. Brodtkorb, and G. Bovim
Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures
J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 342 - 348.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. M. Robertson, N. Cahir, H. G. Burger, P. Mamers, P. I. McCloud, K. Pettersson, and M. McGuckin
Combined Inhibin and CA125 Assays in the Detection of Ovarian Cancer
Clin. Chem., May 1, 1999; 45(5): 651 - 658.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.